Saglam, Funda <br/><br/>
Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-β, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis.  [electronic resource] 

 -  Renal failure  2012 
 - 95-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-6049 
<br/><br/><label>Standard No.: </label>10.3109/0886022X.2011.623498  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Female<br/>Matrix Metalloproteinase Inhibitors<br/>Peritoneal Fibrosis--prevention & control<br/>Pioglitazone<br/>Rats<br/>Rats, Wistar<br/>Thiazolidinediones--therapeutic use<br/>Transforming Growth Factor beta--antagonists & inhibitors